Table 2. Parameters correlated with serum irisin levels.

TOAST, Trial of Org 10172 in Acute Stroke Treatment; HDL, high density lipoprotein.

Variable	Subgroup	N (%)	Mean Rank	r	p
Neurological deficits with a localization	(0=No)<br>(1=Yes)	24 (26.7)<br>66 (73.3)	62.50<br>39.32	-0.395	<0.01
TOAST	1 - Large-artery atherosclerosis<br>2 - Cardioembolism<br>3 - Small-vessel occlusion<br>4 - Stroke of other determined aetiology<br>5 - Stroke of undetermined etiology	27 (30)<br>22 (24.2)<br>9 (10)<br>26 (28.9)<br>6 (6.7)	44.87<br>47.14<br>67.89<br>35.52<br>52.00	-0.053	<0.01
HDL	*	90	*	-0.272	<0.01